# Options MD

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/options-md

- Industry: Healthcare Specialists
- Headquarters: Los Angeles, US
- Website: www.optionsmd.com/
- Total disclosed funding: $2.4M
- Latest round: Seed (Mar 20, 2023)
- Investors on record: 8

## About

Based in California, US, and co-founded by Morgan Hewett and Kyle Pierce in 2020, Options MD, Inc. operates as a telehealth company offering care and treatment-matching software for treatment-resistant depression (TRD). In August 2022, the firm raised USD 2.35 million in pre-seed funding led by investor Bread & Butter Ventures, with participation from other investors including Bright Ventures, Google for Startups, Collab Capital, and M13. In October 2024, Resilience Lab LLC, a portfolio company of Morningside Group and Viewside Capital Partners, acquired Options MD, Inc. from Alumni Ventures Group, Bread & Butter Ventures, Bright Pixel, Ceresti Health, Inc., Collab Capital, Google for Startups, M13, MedMountain Ventures, and Techstars Ventures for an undisclosed amount.

The company provides a personalized care model and treatment-matching platform for severe and treatment-resistant depression to match solutions to severe illnesses and to find and access therapies. A person facing TRD can build his or her profile on the software offered by the company and they will assess the for that whether the person is eligible for telemedicine through Options MD, by assessing the patient’s history with depression, symptoms, lifestyle, overall health, treatment preferences, etc. If the patient is eligible the company will schedule a one-hour intake session and the company’s software through artificial intelligence to match patients to personalized treatment options from the range of more than 200 treatments in its toolkit including EMDR, ACT, DBT, and lifestyle changes.

The firm generates its revenue by offering its healthcare services including 1-hour intake consultation sessions for USD 250, recurring therapy follow-up sessions for USD 120 each, and recurring psych follow-up sessions for USD 150 each.

Options MD plans to utilize its August 2022 funding to expand its clinical operations, and medical research and enhance its proprietary clinical protocols.

## Funding rounds

- Seed, Mar 20, 2023 — Alumni Ventures Group
- Seed, Aug 30, 2022, $2.4M — Techstars, M13, Bright Pixel, Bread & Butter Ventures, Collab Capital, Google for Startups, MedMountain Ventures

## Investors

- Techstars (https://capitalatlas.ai/funds/techstars) — Seed
- M13 (https://capitalatlas.ai/funds/m13) — Seed
- Bright Pixel (https://capitalatlas.ai/funds/bright-pixel) — Seed
- Bread & Butter Ventures (https://capitalatlas.ai/funds/bread-butter-ventures) — Seed
- Collab Capital (https://capitalatlas.ai/funds/collab-capital) — Seed
- Google for Startups (https://capitalatlas.ai/funds/google-for-startups) — Seed
- MedMountain Ventures (https://capitalatlas.ai/funds/medmountain-ventures) — Seed
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed